연구성과로 돌아가기
JCR 2023 저널 목록 (1122 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atencion Primaria | EDICIONES DOYMA S A | 0212-6567 | 1578-1275 | SCIE | PRIMARY HEALTH CARE | 1,479 | 1.8 | Q3 | 58.3 | 41.7 | 18/30 | 1.6 | Q4 | 1.6 | 0.3 | 0.82 | 21/30 | Q3 | 31.67 | 0.001 | 0.223 | 0.316 | Q4 | 60 | 91.7% | 7.3 | 5.1 | 55 | 98.3% | 2025-03-24 17:56:43 | 바로가기 |
| BIOTECHNOLOGY AND BIOPROCESS ENGINEERING | KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING | 1226-8372 | 1976-3816 | SCIE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 3,026 | 2.5 | Q3 | 58.3 | 41.7 | 102/174 | 2.2 | Q3 | 2.2 | 0.8 | 0.58 | 101/174 | Q3 | 42.24 | 0.001 | 0.293 | 0.334 | Q4 | 83 | 78.3% | 8.4 | 7.4 | 65 | 0.0% | 2025-03-24 16:56:59 | 바로가기 |
| BIOTECHNOLOGY PROGRESS | WILEY | 8756-7938 | 1520-6033 | SCIE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 7,266 | 2.5 | Q3 | 58.3 | 41.7 | 102/174 | 2.6 | Q3 | 2.4 | 0.6 | 0.58 | 101/174 | Q3 | 42.24 | 0.003 | 0.575 | 0.454 | Q3 | 93 | 80.6% | 11.8 | 7.4 | 75 | 27.8% | 2025-03-24 16:56:54 | 바로가기 |
| BMC Urology | BMC | 1471-2490 | 1471-2490 | SCIE | UROLOGY & NEPHROLOGY | 2,856 | 1.7 | Q3 | 58.3 | 41.7 | 74/126 | 2.0 | Q3 | 1.7 | 0.2 | 0.64 | 63/126 | Q2 | 50.40 | 0.004 | 0.826 | 0.543 | Q3 | 208 | 89.4% | 4.8 | 7.1 | 186 | 99.8% | 2025-03-24 18:14:58 | 바로가기 |
| Briefings in Functional Genomics | OXFORD UNIV PRESS | 2041-2649 | 2041-2657 | SCIE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 2,012 | 2.5 | Q3 | 58.3 | 41.7 | 102/174 | 3.4 | Q2 | 2.5 | 0.8 | 0.48 | 127/174 | Q3 | 27.30 | 0.002 | 0.349 | 0.877 | Q2 | 61 | 60.7% | 7.9 | 5.6 | 37 | 18.4% | 2025-03-24 16:57:01 | 바로가기 |
| Cardiology Research and Practice | HINDAWI LTD | 2090-8016 | 2090-0597 | SCIE | CARDIAC & CARDIOVASCULAR SYSTEMS | 1,239 | 1.8 | Q3 | 58.3 | 41.7 | 130/222 | 1.9 | Q3 | 1.7 | <0.1 | 0.42 | 139/222 | Q3 | 37.61 | 0.001 | 0.311 | 0.441 | Q3 | 23 | 91.3% | 4.9 | 7.1 | 21 | 99.4% | 2025-03-24 16:58:14 | 바로가기 |
| Current Opinion in Endocrinology Diabetes and Obesity | LIPPINCOTT WILLIAMS & WILKINS | 1752-296X | 1752-2978 | SCIE | ENDOCRINOLOGY & METABOLISM | 3,073 | 2.6 | Q3 | 58.3 | 41.7 | 109/186 | 3.1 | Q3 | 2.5 | 1.2 | 0.44 | 147/186 | Q4 | 21.24 | 0.003 | 0.560 | 0.966 | Q2 | 42 | 16.7% | 7.6 | 5.2 | 7 | 14.7% | 2025-03-24 17:07:40 | 바로가기 |
| EMERGENCY MEDICINE CLINICS OF NORTH AMERICA | W B SAUNDERS CO-ELSEVIER INC | 0733-8627 | 1558-0539 | SCIE | EMERGENCY MEDICINE | 1,645 | 1.3 | Q3 | 58.3 | 41.7 | 32/54 | 2.1 | Q2 | 1.3 | 0.1 | 0.51 | 34/54 | Q3 | 37.96 | 0.001 | 0.316 | 0.605 | Q2 | 46 | 100.0% | 7.9 | 8.3 | 46 | 0.0% | 2025-03-24 17:07:25 | 바로가기 |
| Endocrine Connections | BIOSCIENTIFICA LTD | N/A | 2049-3614 | SCIE | ENDOCRINOLOGY & METABOLISM | 3,457 | 2.6 | Q3 | 58.3 | 41.7 | 109/186 | 2.9 | Q3 | 2.5 | 0.7 | 0.62 | 111/186 | Q3 | 40.59 | 0.006 | 1.258 | 0.777 | Q3 | 159 | 78.6% | 4.4 | 7.7 | 125 | 92.9% | 2025-03-24 17:07:39 | 바로가기 |
| Expert Review of Cardiovascular Therapy | TAYLOR & FRANCIS INC | 1477-9072 | 1744-8344 | ESCI | CARDIAC & CARDIOVASCULAR SYSTEMS | 2,270 | 1.8 | Q3 | 58.3 | 41.7 | 130/222 | 2.1 | Q3 | 1.8 | 0.5 | 0.36 | 157/222 | Q3 | 29.50 | 0.002 | 0.474 | 0.631 | Q3 | 79 | 21.5% | 7.7 | 6.3 | 17 | 8.4% | 2025-03-24 16:58:10 | 바로가기 |
| FAMILY MEDICINE | SOC TEACHERS FAMILY MEDICINE | 0742-3225 | 1938-3800 | SCIE | PRIMARY HEALTH CARE | 2,817 | 1.8 | Q3 | 58.3 | 41.7 | 18/30 | 1.8 | Q4 | 1.3 | 0.7 | 0.89 | 17/30 | Q3 | 45.00 | 0.002 | 0.479 | 0.633 | Q3 | 78 | 98.7% | 13.6 | 5.8 | 77 | 99.6% | 2025-03-24 17:56:42 | 바로가기 |
| FEMINIST REVIEW | SAGE PUBLICATIONS LTD | 0141-7789 | 1466-4380 | SSCI | WOMENS STUDIES | 1,359 | 0.9 | Q3 | 58.3 | 41.7 | 39/66 | 2.4 | Q2 | 0.9 | 0.5 | 0.81 | 27/66 | Q2 | 59.85 | 0.001 | 0.227 | 1.258 | Q1 | 24 | 95.8% | 15.5 | 7.3 | 23 | 24.6% | 2025-03-24 18:16:01 | 바로가기 |
| Frontiers in Chemical Engineering | FRONTIERS MEDIA SA | N/A | 2673-2718 | ESCI | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 631 | 2.5 | Q3 | 58.3 | 41.7 | 102/174 | 2.6 | Q3 | 2.5 | 0.6 | 0.34 | 149/174 | Q4 | 14.66 | 0.001 | 0.206 | 0.489 | Q3 | 53 | 54.7% | 2.2 | 6.1 | 29 | 99.6% | 2025-03-24 16:57:04 | 바로가기 |
| Gender and Language | EQUINOX PUBLISHING LTD | 1747-6321 | 1747-633X | SSCI | WOMENS STUDIES | 252 | 0.9 | Q3 | 58.3 | 41.7 | 39/66 | 1.0 | Q3 | 0.7 | 0.4 | 1.01 | 19/66 | Q2 | 71.97 | 0.001 | 0.134 | 0.591 | Q3 | 17 | 100.0% | 5.5 | 8.3 | 17 | 2.4% | 2025-03-24 18:16:05 | 바로가기 |
| Hormone Research in Paediatrics | KARGER | 1663-2818 | 1663-2826 | SCIE | ENDOCRINOLOGY & METABOLISM | 2,938 | 2.6 | Q3 | 58.3 | 41.7 | 109/186 | 2.9 | Q3 | 2.5 | 1.2 | 0.73 | 89/186 | Q2 | 52.42 | 0.003 | 0.708 | 0.978 | Q2 | 97 | 65.0% | 6.7 | 8.9 | 63 | 27.8% | 2025-03-24 17:07:40 | 바로가기 |
페이지 이동: